Connect Biopharma Holdings Stock Target Price
| CNTB Stock | USD 1.06 0.03 2.91% |
Connect Biopharma Holdings fundamentals help investors to digest information that contributes to Connect Biopharma's financial success or failures. It also enables traders to predict the movement of Connect Stock. The fundamental analysis module provides a way to measure Connect Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Connect Biopharma stock.
Connect | Target Price |
Connect Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Connect Biopharma's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Connect Biopharma could also be used in its relative valuation, which is a method of valuing Connect Biopharma by comparing valuation metrics of similar companies.Connect Biopharma is currently under evaluation in target price category among its peers.
Connect Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.89) % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | (51.28 M) | ||||
| Shares Outstanding | 55.25 M | ||||
| Shares Owned By Insiders | 41.16 % | ||||
| Shares Owned By Institutions | 44.42 % | ||||
| Number Of Shares Shorted | 61.79 K | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 2.43 X | ||||
| EBITDA | (58.37 M) | ||||
| Net Income | (59.38 M) | ||||
| Cash And Equivalents | 1.28 B | ||||
| Cash Per Share | 23.26 X | ||||
| Total Debt | 465 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.58 X | ||||
| Book Value Per Share | 2.00 X | ||||
| Cash Flow From Operations | (47.93 M) | ||||
| Short Ratio | 2.41 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 81 | ||||
| Beta | -0.31 | ||||
| Market Capitalization | 58.57 M | ||||
| Total Asset | 125.89 M | ||||
| Retained Earnings | (539.35 M) | ||||
| Working Capital | 96.71 M | ||||
| Net Asset | 125.89 M |
About Connect Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Connect Biopharma Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Connect Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Connect Biopharma Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Connect Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Connect Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Connect Biopharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Connect Biopharma Holdings Stock:Check out Connect Biopharma Piotroski F Score and Connect Biopharma Altman Z Score analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Revenue Per Share 0.438 | Return On Assets (0.12) | Return On Equity (0.18) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.